104 related articles for article (PubMed ID: 36065160)
1. Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid Testing.
Peck Palmer O; Hasskamp JH; La HS; Pramod Patwardhan P; Ghumman S; Baloda V; Jung Y; Wheeler SE
Lab Med; 2023 Mar; 54(2):e54-e57. PubMed ID: 36065160
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay.
Hörber S; Drees C; Ganzenmueller T; Schmauder K; Peter S; Biskup D; Peter A
Clin Chem Lab Med; 2022 Aug; 60(9):1478-1485. PubMed ID: 35700973
[TBL] [Abstract][Full Text] [Related]
3. High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load.
Ríos E; Medrano S; Alvarez M; Valderrama MJ; Vallejo L; Delgado-Iribarren A; Culebras E
Int Microbiol; 2023 Aug; 26(3):471-474. PubMed ID: 36527576
[TBL] [Abstract][Full Text] [Related]
4. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis.
Lippi G; Henry BM; Plebani M
Clin Chem Lab Med; 2023 Jun; 61(7):1133-1139. PubMed ID: 36634305
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
Cybulski DJ; Matthews Z; Kieffer JW; Casey TM; Osuna AB; Kasper K; Frankel DN; Aden J; Yun HC; Marcus JE
Clin Infect Dis; 2024 Jan; 78(1):65-69. PubMed ID: 37610361
[TBL] [Abstract][Full Text] [Related]
7. Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of "Variants of Concern": Implications for Clinical Use.
Gourgeon A; Soulier A; Audureau É; Khouider S; Galbin A; Langlois C; Bouvier-Alias M; Rodriguez C; Chevaliez S; Pawlotsky JM; Fourati S
Microbiol Spectr; 2022 Aug; 10(4):e0115722. PubMed ID: 35862982
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs).
Kohmer N; Rabenau HF; Hoehl S; Kortenbusch M; Ciesek S; Berger A
J Virol Methods; 2021 May; 291():114102. PubMed ID: 33607117
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
[TBL] [Abstract][Full Text] [Related]
10. Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.
Zupin L; Fontana F; Clemente L; Ruscio M; Crovella S
Braz J Microbiol; 2022 Sep; 53(3):1271-1277. PubMed ID: 35446012
[TBL] [Abstract][Full Text] [Related]
11. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
[TBL] [Abstract][Full Text] [Related]
12. Efficiency evaluation of a SARS-CoV-2 diagnostic strategy combining high throughput quantitative antigen immunoassay and real time PCR.
Bernasconi L; Neyer P; Oberle M; Schmid B; Martin E; Fankhauser H; Haubitz S; Hammerer-Lercher A
Clin Chem Lab Med; 2023 Aug; 61(9):1661-1669. PubMed ID: 36947812
[TBL] [Abstract][Full Text] [Related]
13. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.
Pray IW; Ford L; Cole D; Lee C; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie D; Cherney B; Kirby M; Fajardo G; Caudill M; Langolf K; Kahrs J; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker P; Folster J; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard R; Killerby M;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1642-1647. PubMed ID: 33382679
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.
Prince-Guerra JL; Almendares O; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Shewmaker PL; Medrzycki M; Wong P; Jain S; Tejada-Strop A; Rogers S; Emery B; Wang H; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg NJ; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):100-105. PubMed ID: 33476316
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
Flinck H; Aittoniemi J
J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
[TBL] [Abstract][Full Text] [Related]
16. What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life.
Roger S; Lefeuvre C; Pivert A; Ducancelle A; Savary D; Bouthry É; Le Guillou-Guillemette H
J Med Virol; 2022 Apr; 94(4):1723-1727. PubMed ID: 34873718
[TBL] [Abstract][Full Text] [Related]
17. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
[TBL] [Abstract][Full Text] [Related]
18. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests.
Kahn M; Schuierer L; Bartenschlager C; Zellmer S; Frey R; Freitag M; Dhillon C; Heier M; Ebigbo A; Denzel C; Temizel S; Messmann H; Wehler M; Hoffmann R; Kling E; Römmele C
BMC Infect Dis; 2021 Aug; 21(1):798. PubMed ID: 34376187
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
Hohl CM; Hau JP; Vaillancourt S; Grant J; Brooks SC; Morrison LJ; Perry JJ; Rosychuk RJ;
JAMA Netw Open; 2022 Oct; 5(10):e2236288. PubMed ID: 36223119
[TBL] [Abstract][Full Text] [Related]
20. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
